CN113876744A - Sanfu plaster for treating chronic bronchitis and preparation method thereof - Google Patents
Sanfu plaster for treating chronic bronchitis and preparation method thereof Download PDFInfo
- Publication number
- CN113876744A CN113876744A CN202111295067.9A CN202111295067A CN113876744A CN 113876744 A CN113876744 A CN 113876744A CN 202111295067 A CN202111295067 A CN 202111295067A CN 113876744 A CN113876744 A CN 113876744A
- Authority
- CN
- China
- Prior art keywords
- patch
- rhizoma
- chronic bronchitis
- sanfu
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010006458 Bronchitis chronic Diseases 0.000 title claims abstract description 41
- 206010006451 bronchitis Diseases 0.000 title claims abstract description 41
- 208000007451 chronic bronchitis Diseases 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000011505 plaster Substances 0.000 title abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 70
- 241000218176 Corydalis Species 0.000 claims abstract description 45
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 33
- 235000008397 ginger Nutrition 0.000 claims abstract description 33
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 30
- 235000006463 Brassica alba Nutrition 0.000 claims abstract description 26
- 244000140786 Brassica hirta Species 0.000 claims abstract description 26
- 235000011371 Brassica hirta Nutrition 0.000 claims abstract description 26
- 241000758794 Asarum Species 0.000 claims abstract description 22
- 229940079593 drug Drugs 0.000 claims abstract description 22
- 241000220261 Sinapis Species 0.000 claims abstract description 21
- 210000000582 semen Anatomy 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 241000234314 Zingiber Species 0.000 claims description 30
- 241000701408 Euphorbia kansui Species 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 16
- 239000002674 ointment Substances 0.000 claims description 14
- 230000001681 protective effect Effects 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 27
- 206010011224 Cough Diseases 0.000 abstract description 18
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 18
- 208000026435 phlegm Diseases 0.000 abstract description 18
- 210000004072 lung Anatomy 0.000 abstract description 13
- 208000002193 Pain Diseases 0.000 abstract description 9
- 238000010792 warming Methods 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 230000008961 swelling Effects 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 5
- 208000011580 syndromic disease Diseases 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 206010036790 Productive cough Diseases 0.000 abstract description 3
- 244000273928 Zingiber officinale Species 0.000 abstract description 3
- 238000001467 acupuncture Methods 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000004087 circulation Effects 0.000 abstract description 3
- 238000010926 purge Methods 0.000 abstract description 3
- 230000004936 stimulating effect Effects 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 208000004880 Polyuria Diseases 0.000 abstract description 2
- 239000002671 adjuvant Substances 0.000 abstract description 2
- 230000035619 diuresis Effects 0.000 abstract description 2
- 230000024121 nodulation Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 210000003802 sputum Anatomy 0.000 abstract description 2
- 208000024794 sputum Diseases 0.000 abstract description 2
- 230000009466 transformation Effects 0.000 abstract description 2
- 208000006673 asthma Diseases 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010016807 Fluid retention Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 4
- -1 isoanisole Chemical compound 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 2
- ZYRBXTNFHYZHSK-UHFFFAOYSA-N 1-(2,4,6-Trimethoxyphenyl)-1,3-butanedione Chemical compound COC1=CC(OC)=C(C(=O)CC(C)=O)C(OC)=C1 ZYRBXTNFHYZHSK-UHFFFAOYSA-N 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CAHGCLMLTWQZNJ-WZLOIPHISA-N Euphol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@@]2(C)[C@H]([C@@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-WZLOIPHISA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 206010044302 Tracheitis Diseases 0.000 description 2
- 206010047924 Wheezing Diseases 0.000 description 2
- 241000234299 Zingiberaceae Species 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 2
- 235000002780 gingerol Nutrition 0.000 description 2
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- HUJXHFRXWWGYQH-UHFFFAOYSA-O sinapine Chemical compound COC1=CC(\C=C\C(=O)OCC[N+](C)(C)C)=CC(OC)=C1O HUJXHFRXWWGYQH-UHFFFAOYSA-O 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- BAPAICNRGIBFJT-UHFFFAOYSA-O (4-Hydroxybenzoyl)choline Chemical compound C[N+](C)(C)CCOC(=O)C1=CC=C(O)C=C1 BAPAICNRGIBFJT-UHFFFAOYSA-O 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- FOSYZKSOJUQLTD-UHFFFAOYSA-N 20-Deoxyingenol Natural products C1=C(C)C(O)C2(O)C(O)C(C)=CC32C(C)CC2C(C)(C)C2C1C3=O FOSYZKSOJUQLTD-UHFFFAOYSA-N 0.000 description 1
- FOSYZKSOJUQLTD-NHPMXQBPSA-N 20-deoxyingenol Chemical compound C1=C(C)[C@@H](O)[C@]2(O)[C@@H](O)C(C)=C[C@]32[C@H](C)C[C@H]2C(C)(C)[C@H]2[C@H]1C3=O FOSYZKSOJUQLTD-NHPMXQBPSA-N 0.000 description 1
- AMKMYXVFAOJGGQ-UHFFFAOYSA-N 4-(methylaminomethyl)phenol Chemical compound CNCC1=CC=C(O)C=C1 AMKMYXVFAOJGGQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000758795 Aristolochiaceae Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- NFHFNBFYZIJLKZ-UHFFFAOYSA-N Asarinin Natural products CC1(OCC2C1COC2c3ccc4OCOc4c3)c5ccc6OCOc6c5 NFHFNBFYZIJLKZ-UHFFFAOYSA-N 0.000 description 1
- 241001289295 Asarum sieboldii Species 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- QFPQAPVPUNXXDR-UHFFFAOYSA-N Euphol Natural products CC(=CCCCC1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3)C QFPQAPVPUNXXDR-UHFFFAOYSA-N 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- VEBVPUXQAPLADL-UHFFFAOYSA-N Ingenol Natural products C1=C(CO)C(O)C2(O)C(O)C(C)=CC32C(C)CC2C(C)(C)C2C1C3=O VEBVPUXQAPLADL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 241000146029 Lindera aggregata Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000218180 Papaveraceae Species 0.000 description 1
- YPWHZCPMOQGCDQ-UHFFFAOYSA-N Populnin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=CC(O)=CC=3)OC2=C1 YPWHZCPMOQGCDQ-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N Tetrahydropalmatine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- RKFAZBXYICVSKP-AATRIKPKSA-N alpha-asarone Chemical compound COC1=CC(OC)=C(\C=C\C)C=C1OC RKFAZBXYICVSKP-AATRIKPKSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229930006974 beta-terpinene Natural products 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- VRSRXLJTYQVOHC-YEJXKQKISA-N corydaline Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(OC)=C1OC VRSRXLJTYQVOHC-YEJXKQKISA-N 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 208000016253 exhaustion Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- VEBVPUXQAPLADL-POYOOMFHSA-N ingenol Chemical compound C1=C(CO)[C@@H](O)[C@]2(O)[C@@H](O)C(C)=C[C@]32[C@H](C)C[C@H]2C(C)(C)[C@H]2[C@H]1C3=O VEBVPUXQAPLADL-POYOOMFHSA-N 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- JDEHKSHYQXNASH-UHFFFAOYSA-N kaempferol-3-O-beta-D-glucopyranoside Natural products OCC1OC(COC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)cc4)C(O)C(O)C1O JDEHKSHYQXNASH-UHFFFAOYSA-N 0.000 description 1
- ZZZILDYSXRHUNY-UHFFFAOYSA-N kaempferol-3-O-glucoside Natural products OC1OC(COC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)cc4)C(O)C(O)C1O ZZZILDYSXRHUNY-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- AEQDJSLRWYMAQI-KRWDZBQOSA-N tetrahydropalmatine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-KRWDZBQOSA-N 0.000 description 1
- 108010058651 thioglucosidase Proteins 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
- SCWPFSIZUZUCCE-UHFFFAOYSA-N β-terpinene Chemical compound CC(C)C1=CCC(=C)CC1 SCWPFSIZUZUCCE-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Sanfu plaster for treating chronic bronchitis and a preparation method thereof, belonging to the technical field of traditional Chinese medicine treatment. The traditional Chinese medicine composition adopted in the Sanfu plaster is prepared from the following raw material medicines: semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari, radix kansui and rhizoma Zingiberis recens juice. The Sanfu plaster is used for treating chronic bronchitis by adopting the treatment principle of expelling wind and eliminating evil, relieving cough and reducing sputum of traditional Chinese medicine, wherein the white mustard seed is warm in nature and pungent in taste, enters lung channels and stomach channels, promotes qi circulation and dryness-phlegm, and is a monarch drug for resolving masses and reducing swelling; rhizoma corydalis has effects of promoting blood circulation, removing blood stasis, regulating qi-flowing and relieving pain; the asarum can expel wind, dispel cold, dredge orifices, relieve pain, warm lung and eliminate phlegm; the dried ginger, the white mustard seed and the white mustard seed are used for dispelling cold and reducing phlegm. Kansui root, radix kansui, as an adjuvant drug and ginger juice, has the effects of purging water and resolving fluid retention, dispersing swelling and dissipating nodulation, dispelling cold and relieving exterior syndrome, as a guiding drug, assisting transportation and transformation, and harmonizing the other drugs. The traditional Chinese medicine composition has the effects of warming the interior, dispelling cold, promoting diuresis, eliminating phlegm, warming the channels, dredging collaterals and stimulating acupuncture points by combining the medicines.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicine treatment, in particular to a Sanfu patch for treating chronic bronchitis and a preparation method thereof.
Background
The chronic bronchitis is the most common chronic inflammatory pathological changes of the respiratory tract, the main diseased parts are the bronchus, the trachea and the mucous tissues around the bronchus, the disease is easy to relapse, and the cure difficulty is higher. At present, the western medicine mainly aims at relieving cough, eliminating phlegm, relieving asthma and resisting inflammation for the chronic bronchitis, and can relieve the clinical symptoms of patients, but the condition of the patients cannot be reversed, and the lung function is continuously reduced. The chronic bronchitis is classified into 'asthma syndrome' and 'cough' in the traditional Chinese medicine, the causes of the chronic bronchitis are external six excesses of pathogenic toxin and dysfunction of internal organs, wind pathogen in six excesses is the long of a hundred diseases, the lung is delicate and delicate, the wind pathogen attacks the lung, the lung is caused to lose and descend, the lung qi is upward adverse, the wind pathogen is removed but not exhausted, and the cough is caused to repeatedly attack and delay and heal.
The cold weather in autumn and winter easily causes repeated attack of clinical symptoms of patients with chronic bronchitis, the traditional Chinese medicine advocates treatment in winter in summer, and the three-volt day is the most vigorous yang qi, so that the traditional Chinese medicine has positive significance in treating lung lesions. At present, sanfu plaster for treating chronic bronchitis is available, but the efficacy is not obvious and the treatment effect is not obvious.
Disclosure of Invention
The invention aims to provide a Sanfu paste for treating chronic bronchitis and a preparation method thereof, and aims to solve the problems that the existing Sanfu paste for treating chronic bronchitis is not obvious in effect and not obvious in treatment effect.
The technical scheme for solving the technical problems is as follows:
a traditional Chinese medicine composition adopted in the Sanfu patch is prepared from the following raw material medicines: semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari, radix kansui and rhizoma Zingiberis recens juice;
wherein the mass ratio of white mustard seed, corydalis tuber, dried ginger, asarum and kansui root is (0.5-2): (2-4): 1-3): 2-4.
Further, the traditional Chinese medicine composition adopted in the sanfu patch for treating chronic bronchitis is prepared from the following raw material medicines: semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari, radix kansui and rhizoma Zingiberis recens juice;
wherein the mass ratio of white mustard seed, corydalis tuber, dried ginger, asarum and euphorbia kansui is (0.5-1.5): (2.5-3.5): (1.5-2.5): 2.5-3.5.
Further, the traditional Chinese medicine composition adopted in the sanfu patch for treating chronic bronchitis is prepared from the following raw material medicines: semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari, radix kansui and rhizoma Zingiberis recens juice;
wherein the mass ratio of the white mustard seed to the corydalis tuber to the dried ginger to the asarum to the euphorbia kansui is 1:3:2:3: 3.
Furthermore, in the traditional Chinese medicine composition adopted by the Sanfu patch, the mass ratio of the ginger juice to the total mass of the white mustard seed, the corydalis tuber, the dried ginger, the asarum and the euphorbia kansui is (1-1.5): 1.
The invention also provides a preparation method of the Sanfu patch for treating chronic bronchitis, which comprises the following steps:
(1) pulverizing semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari and radix kansui, and sieving to obtain medicinal powder;
(2) mixing rhizoma Zingiberis recens juice with the medicinal powder, and concocting into paste to obtain unguent;
(3) the ointment is prepared into a medicament which is attached to the center of the thin patch, and a protective patch is attached to the thin patch to obtain the Sanfu patch for treating the chronic bronchitis.
Further, the powder crushed in the step (1) is sieved by a 100-120-mesh sieve.
Further, the dosage form prepared in step (3) is 2cm × 2cm, 1g, and is suitable for children. In the present invention, the child is directed to a child under the age of 12 years.
Further, the size of the medicament prepared in the step (3) is 3cm multiplied by 3cm, 1.5g, and the medicament is used for adults. In the present invention, the adult is aimed at the age of 13 years or more.
White mustard seed, the name of traditional Chinese medicine. Is seed of Brassicaceae plant caulis et folium Sinapis Albae. Has effects of warming lung, eliminating phlegm, activating qi-flowing, resolving hard mass and relieving swelling. It is mainly used for treating cold phlegm cough and asthma, fluid retention, dorsal furuncle, multiple abscess, numbness of limbs, and arthralgia. The seeds contain glucosinolates and are filled with sinapioside. It also contains fatty oil, myrosinase, sinapine and lysine, arginine, histidine, etc. Also contains 4-hydroxybenzoyl choline and 4-hydroxybenzyl methylamine. The pharmacological effects are as follows: respiratory system effects: a small dose can cause reflex tracheal secretion to increase, and has the effects of nausea and phlegm elimination. Effect on skin mucosa: the Sinapis Albae oil obtained by hydrolyzing sinapioside has strong irritation, and can be used for treating skin hyperemia and foaming. Effects on the digestive system: the semen Sinapis Albae powder has effects of promoting salivary secretion, increasing amylase activity, stimulating gastric mucosa in small amount, increasing secretion of gastric juice and pancreatic juice, and promoting vomiting in large amount. Role of pathogenic microorganisms: the water infusion has effect in inhibiting dermatophytes.
Corydalis tuber, name of Chinese medicine. Is dried tuber of corydalis of Papaveraceae. Has effects in promoting blood circulation, activating qi-flowing, and relieving pain. It is mainly indicated for various pain syndromes due to qi and blood stagnation. Such as thoracic obstruction, heart pain, liver and stomach pain, dysmenorrhea, menoxenia, puerperal abdominal pain due to blood stasis, cold hernia, traumatic injury, swelling pain due to blood stasis, and rheumatalgia. Contains alkaloids (corydalis A, B, C, D, G, C, N, and S), starch, mucilage, resin, volatile oil, and neutral substance. The pharmacological effects are as follows: effects on the nervous system: tetrahydropalmatine has analgesic, hypnotic, tranquilizing, and tranquilizing effects. The A and the Pharbitidis have obvious analgesic effect and certain hypnotic, sedative and tranquilization effects. Influence on the circulation system: the alcohol extract of rhizoma corydalis can dilate coronary artery, reduce coronary artery resistance, increase coronary artery flow, and improve anoxia resistance. The rhizoma corydalis total alkaloids have effects of resisting arrhythmia and myocardial ischemia, dilating peripheral blood vessel, lowering blood pressure, and slowing down heart rate. Effects on the digestive system: the rhizoma corydalis total alkaloids have antiulcer and gastric secretion inhibiting effects. The rhizoma corydalis extract has exciting effect on guinea pig isolated intestine, and can resist 5-hydroxytryptamine induced shrinkage of rat isolated stomach and colon. Effects on the endocrine System: promote the pituitary gland of the rat to secrete adrenocorticotropic hormone, influence the function of the thyroid gland and increase the weight of the thyroid gland. In addition, Yanhusuo has the actions of relaxing muscles, stopping vomiting and reducing body temperature.
Dried ginger, named as traditional Chinese medicine. Is dried rhizome of Zingiber officinale Roscoe of Zingiberaceae. Has the effects of warming spleen and stomach for dispelling cold, restoring yang and dredging collaterals, and warming lung and resolving fluid retention. It can be used for treating abdominal psychroalgia, emesis, diarrhea, yang exhaustion, cough and asthma due to cold-fluid retention, and arthralgia due to cold-dampness. Contains volatile oil about 2%, and mainly contains zingiberene, phellandrene, camphene, zingiberone, gingerol, zingiberone, borneol, gingerol, citral, etc. It also contains resin, starch and amino acids. The pharmacological effects are as follows: has tranquilizing, analgesic, antiinflammatory, anticoagulant, anoxia resisting, and other effects, and is effective in treating cardiovascular and adrenal cortex function and digestive system function.
Asarum herb, the name of traditional Chinese medicine. Is the whole herb of Aristolochiaceae plant Asarum sieboldii. Has effects of dispelling pathogenic wind, dispelling cold, inducing resuscitation, relieving pain, warming lung, and eliminating phlegm. It is used to treat wind-cold type common cold, headache, toothache, nasal obstruction, nasal sinusitis, rheumatic arthralgia, phlegm and fluid retention, asthma and cough. Contains volatile oil, and mainly contains methyl eugenol, eugenone, safrole, beta-pinene, alpha-pinene, borneol, isoanisole, asarinin, etc. In addition, contains racemization-potassium-removing lindera aggregate alkali. The trace elements include potassium, sodium, magnesium, calcium, iron, manganese, copper, zinc, etc. And further contains kaempferol, kaempferol 3-O-beta-D-glucopyranoside, gamma-terpinene, beta-terpinene, alpha-arborvitae, asarone and (-) -asarone.
Gan sui, the name of traditional Chinese medicine. Is root tuber of Euphorbia kansui of Euphorbiaceae. Has the effects of purging water, expelling retained fluid, relieving swelling, and dispersing pathogenic accumulation. It is indicated for edema, abdominal dropsy, phlegm and fluid accumulation, dyspnea with cough, difficult urination and defecation. The product contains euphadienol, alpha-euphol, kansui alcohol, gamma-cirsium japonicum sterol, kansui sterol and alpha-cirsium japonicum sterol. It has also been reported that the roots still contain derivatives (I), (II) of 20-deoxyingenol, derivatives (III) of ingenol, derivatives (IV) of 13-oxoingenol, euphorbia kansui terpene ester A and euphorbia kansui terpene ester B, all of which are toxic, and beta-sitosterol.
Ginger juice, named as Chinese medicinal material. The product is prepared by cleaning rhizoma Zingiberis recens of Zingiberaceae, mashing, and mixing with juice. The main functional indications are as follows: has the effects of dispelling cold, relieving exterior syndrome, lowering adverse qi, relieving vomit, eliminating phlegm and relieving cough, and can be used for treating nausea, emesis, cough and excessive phlegm.
The invention has the following beneficial effects:
the Sanfu plaster is used for treating chronic bronchitis by adopting the treatment principle of expelling wind and eliminating evil, relieving cough and reducing sputum of traditional Chinese medicine, wherein the white mustard seed is warm in nature and pungent in taste, enters lung channels and stomach channels, promotes qi circulation and dryness-phlegm, and is a monarch drug for resolving masses and reducing swelling; rhizoma corydalis has effects of promoting blood circulation, removing blood stasis, regulating qi-flowing and relieving pain; the asarum can expel wind, dispel cold, dredge orifices, relieve pain, warm lung and eliminate phlegm; the dried ginger, the white mustard seed and the white mustard seed are used for dispelling cold and reducing phlegm. Kansui root, radix kansui, as an adjuvant drug and ginger juice, has the effects of purging water and resolving fluid retention, dispersing swelling and dissipating nodulation, dispelling cold and relieving exterior syndrome, as a guiding drug, assisting transportation and transformation, and harmonizing the other drugs. The traditional Chinese medicine composition has the effects of warming the interior, dispelling cold, promoting diuresis, eliminating phlegm, warming the channels, dredging collaterals and stimulating acupuncture points by combining the medicines.
Detailed Description
The principles and features of this invention are described below in conjunction with embodiments, which are included to explain the invention and not to limit the scope of the invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
Example 1:
the traditional Chinese medicine composition adopted in the sanfu patch for treating chronic bronchitis in the embodiment is prepared from the following raw material medicines: semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari, radix kansui and rhizoma Zingiberis recens juice;
wherein the mass ratio of white mustard seed, corydalis tuber, dried ginger, asarum and euphorbia kansui is 0.5:2:1: 2.
The mass ratio of the ginger juice to the total mass of the white mustard seed, the corydalis tuber, the dried ginger, the asarum and the euphorbia kansui is 1: 1.
The preparation method of the patch for treating chronic bronchitis in the embodiment comprises the following steps:
(1) pulverizing semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari and radix kansui, and sieving with 100 mesh sieve to obtain medicinal powder;
(2) mixing rhizoma Zingiberis recens juice with the medicinal powder, and concocting into paste to obtain unguent;
(3) the ointment is prepared into a medicament which is attached to the center of the thin patch, and a protective patch is attached to the thin patch to obtain the Sanfu patch for treating the chronic bronchitis.
The specification of the medicament prepared in the step (3) of the invention is 2cm multiplied by 2cm, 1g, and the medicament is used for children; or 3cm × 3cm, 1.5g, for adults.
Example 2:
the traditional Chinese medicine composition adopted in the sanfu patch for treating chronic bronchitis in the embodiment is prepared from the following raw material medicines: semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari, radix kansui and rhizoma Zingiberis recens juice;
wherein the mass ratio of the white mustard seed to the corydalis tuber to the dried ginger to the asarum to the euphorbia kansui is 0.5:2.5:1.5:1.5: 2.5.
The mass ratio of the ginger juice to the total mass of the white mustard seed, the corydalis tuber, the dried ginger, the asarum and the euphorbia kansui is 1.2: 1.
The preparation method of the patch for treating chronic bronchitis in the embodiment comprises the following steps:
(1) pulverizing semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari and radix kansui, and sieving with 100 mesh sieve to obtain medicinal powder;
(2) mixing rhizoma Zingiberis recens juice with the medicinal powder, and concocting into paste to obtain unguent;
(3) the ointment is prepared into a medicament which is attached to the center of the thin patch, and a protective patch is attached to the thin patch to obtain the Sanfu patch for treating the chronic bronchitis.
The specification of the medicament prepared in the step (3) of the invention is 2cm multiplied by 2cm, 1g, and the medicament is used for children; or 3cm × 3cm, 1.5g, for adults.
Example 3:
the traditional Chinese medicine composition adopted in the sanfu patch for treating chronic bronchitis in the embodiment is prepared from the following raw material medicines: semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari, radix kansui and rhizoma Zingiberis recens juice;
wherein the mass ratio of the white mustard seed to the corydalis tuber to the dried ginger to the asarum to the euphorbia kansui is 1:3:2:3: 3.
The mass ratio of the ginger juice to the total mass of the white mustard seed, the corydalis tuber, the dried ginger, the asarum and the euphorbia kansui is 1.3: 1.
The preparation method of the patch for treating chronic bronchitis in the embodiment comprises the following steps:
(1) pulverizing semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari and radix kansui, and sieving with 110 mesh sieve to obtain medicinal powder;
(2) mixing rhizoma Zingiberis recens juice with the medicinal powder, and concocting into paste to obtain unguent;
(3) the ointment is prepared into a medicament which is attached to the center of the thin patch, and a protective patch is attached to the thin patch to obtain the Sanfu patch for treating the chronic bronchitis.
The specification of the medicament prepared in the step (3) of the invention is 2cm multiplied by 2cm, 1g, and the medicament is used for children; or 3cm × 3cm, 1.5g, for adults.
Example 4:
the traditional Chinese medicine composition adopted in the sanfu patch for treating chronic bronchitis in the embodiment is prepared from the following raw material medicines: semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari, radix kansui and rhizoma Zingiberis recens juice;
wherein the mass ratio of the white mustard seed to the corydalis tuber to the dried ginger to the asarum to the euphorbia kansui is 1.5:3.5:2.5:2.5: 3.5.
The mass ratio of the ginger juice to the total mass of the white mustard seed, the corydalis tuber, the dried ginger, the asarum and the euphorbia kansui is 1.4: 1.
The preparation method of the patch for treating chronic bronchitis in the embodiment comprises the following steps:
(1) crushing white mustard seed, corydalis tuber, dried ginger, asarum and kansui root, and sieving by a sieve of 100-120 meshes to obtain medicinal powder;
(2) mixing rhizoma Zingiberis recens juice with the medicinal powder, and concocting into paste to obtain unguent;
(3) the ointment is prepared into a medicament which is attached to the center of the thin patch, and a protective patch is attached to the thin patch to obtain the Sanfu patch for treating the chronic bronchitis.
The specification of the medicament prepared in the step (3) of the invention is 2cm multiplied by 2cm, 1g, and the medicament is used for children; or 3cm × 3cm, 1.5g, for adults.
Example 5:
the traditional Chinese medicine composition adopted in the sanfu patch for treating chronic bronchitis in the embodiment is prepared from the following raw material medicines: semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari, radix kansui and rhizoma Zingiberis recens juice;
wherein the mass ratio of the white mustard seed to the corydalis tuber to the dried ginger to the asarum to the euphorbia kansui is 2:4:3:3: 4.
The mass ratio of the ginger juice to the total mass of the white mustard seed, the corydalis tuber, the dried ginger, the asarum and the euphorbia kansui is 1.5:1.
The preparation method of the patch for treating chronic bronchitis in the embodiment comprises the following steps:
(1) pulverizing semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari and radix kansui, and sieving with 120 mesh sieve to obtain medicinal powder;
(2) mixing rhizoma Zingiberis recens juice with the medicinal powder, and concocting into paste to obtain unguent;
(3) the ointment is prepared into a medicament which is attached to the center of the thin patch, and a protective patch is attached to the thin patch to obtain the Sanfu patch for treating the chronic bronchitis.
The specification of the medicament prepared in the step (3) of the invention is 2cm multiplied by 2cm, 1g, and the medicament is used for children; or 3cm × 3cm, 1.5g, for adults.
The compatible acupuncture points of the Sanfu patch for treating chronic bronchitis in the invention are selected from the following components: the large spine, lung, heart, septum and Tiantu.
Use contraindications: pregnant women, pulmonary tuberculosis, severe cardiopulmonary function diseases, severe hypertension, and diabetes.
Note that: the patch is applied to children 3-14 years old for 1-2 hours, and the patch is applied to children above 14 years old for 2-4 hours.
Application cases are as follows:
1. when a certain woman in the family is 88 years old and patients have serious tracheitis, cough and asthma continue for about one month when weather changes, the Sanfu paste disclosed by the invention is pasted from 09 years, and the symptoms of the patients are obviously relieved after the Sanfu paste is continuously pasted for three years, so far, the Sanfu paste is continuously pasted for 13 years.
2. Xuan, male, 52 years old, patient will have tracheitis from childhood, cough, expectoration with wheezing will appear in winter every year about two months, from 09 years, the three-volt patch of the invention is attached, symptoms basically disappear after three years of continuous attachment, and then 10 years of continuous attachment, so far, there is no cough for several days in winter.
3. When a certain male is in the age of 68, the patient suffers from cough, cough with large amount of phlegm, wheeze and the like after being cooled, the cough frequency is obviously reduced compared with the prior art after the three-volt patch is attached for the second year from 09 years, the cough time and symptoms are obviously relieved, and the symptoms basically disappear after the three-volt patch is continuously attached for four years.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (8)
1. The Sanfu patch for treating chronic bronchitis is characterized in that a traditional Chinese medicine composition adopted in the Sanfu patch is prepared from the following raw material medicines: semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari, radix kansui and rhizoma Zingiberis recens juice;
wherein the mass ratio of white mustard seed, corydalis tuber, dried ginger, asarum and kansui root is (0.5-2): (2-4): 1-3): 2-4.
2. The patch for treating chronic bronchitis according to claim 1, wherein the traditional Chinese medicine composition adopted in the patch is prepared from the following raw material medicines: semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari, radix kansui and rhizoma Zingiberis recens juice;
wherein the mass ratio of white mustard seed, corydalis tuber, dried ginger, asarum and euphorbia kansui is (0.5-1.5): (2.5-3.5): (1.5-2.5): 2.5-3.5.
3. The patch for treating chronic bronchitis according to claim 2, wherein the traditional Chinese medicine composition adopted in the patch is prepared from the following raw material medicines: semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari, radix kansui and rhizoma Zingiberis recens juice;
wherein the mass ratio of the white mustard seed to the corydalis tuber to the dried ginger to the asarum to the euphorbia kansui is 1:3:2:3: 3.
4. The patch for treating chronic bronchitis according to any one of claims 1 to 3, wherein the traditional Chinese medicine composition adopted by the patch is such that the mass ratio of the ginger juice to the total mass of white mustard seed, corydalis tuber, dried ginger, asarum and euphorbia kansui is (1-1.5): 1.
5. A method of preparing a patch for use in the treatment of chronic bronchitis according to any one of claims 1 to 4, comprising the steps of:
(1) pulverizing semen Sinapis Albae, rhizoma corydalis, Zingiberis rhizoma, herba asari and radix kansui, and sieving to obtain medicinal powder;
(2) mixing rhizoma Zingiberis recens juice with the medicinal powder, and concocting into paste to obtain unguent;
(3) the ointment is prepared into a medicament which is attached to the center of the thin patch, and a protective patch is attached to the thin patch to obtain the Sanfu patch for treating the chronic bronchitis.
6. The preparation method of a Sanfu patch for treating chronic bronchitis according to claim 5, wherein the Sanfu patch is crushed in the step (1) and then screened by a 100-120-mesh sieve.
7. The method of claim 5, wherein the dosage form of step (3) is 2cm x 2cm, 1g for children.
8. The method of claim 5, wherein the dosage form of the patch prepared in step (3) is 3cm x 3cm, 1.5g, and is suitable for adults.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111295067.9A CN113876744A (en) | 2021-11-03 | 2021-11-03 | Sanfu plaster for treating chronic bronchitis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111295067.9A CN113876744A (en) | 2021-11-03 | 2021-11-03 | Sanfu plaster for treating chronic bronchitis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113876744A true CN113876744A (en) | 2022-01-04 |
Family
ID=79016325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111295067.9A Pending CN113876744A (en) | 2021-11-03 | 2021-11-03 | Sanfu plaster for treating chronic bronchitis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113876744A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810844A (en) * | 2010-04-23 | 2010-08-25 | 浙江省中医院 | External plaster for preventing disease and manufacturing method thereof |
| CN104436084A (en) * | 2013-09-13 | 2015-03-25 | 孟祥海 | Acupoint application plaster for treating asthma and preparation method of acupoint application plaster |
| CN106581178A (en) * | 2016-12-15 | 2017-04-26 | 忠县中医医院 | Dog-days paste for preventing and treating asthma and preparation method of dog-days paste |
-
2021
- 2021-11-03 CN CN202111295067.9A patent/CN113876744A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810844A (en) * | 2010-04-23 | 2010-08-25 | 浙江省中医院 | External plaster for preventing disease and manufacturing method thereof |
| CN104436084A (en) * | 2013-09-13 | 2015-03-25 | 孟祥海 | Acupoint application plaster for treating asthma and preparation method of acupoint application plaster |
| CN106581178A (en) * | 2016-12-15 | 2017-04-26 | 忠县中医医院 | Dog-days paste for preventing and treating asthma and preparation method of dog-days paste |
Non-Patent Citations (2)
| Title |
|---|
| 常佳婧: ""喘敷贴"三伏穴位贴敷预防冷哮证的临床研究", 《中西医结合研究》, vol. 5, no. 1, pages 5 - 8 * |
| 陈敖忠等: "《秘方验方妙治疑难病 第4版》", pages: 45 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103735927B (en) | A kind of Chinese medicine composition for the treatment of acute stage of gout and preparation method thereof | |
| CN103417894B (en) | Traditional Chinese medicine preparation for treating gastric ulcer | |
| KR101456937B1 (en) | Composition comprising the extracts of natural material for controling or treating obesity | |
| CN106692909A (en) | Pyrus pyrifolia tree viscum coloratum grease with lung-clearing and phlegm-eliminating effects | |
| CN113876744A (en) | Sanfu plaster for treating chronic bronchitis and preparation method thereof | |
| CN1132616C (en) | Traditional Chinese medicine for treating arthralgia-syndrome | |
| CN104524190A (en) | Medicament for treating rheumatic lumbar disease and preparation method thereof | |
| CN103751650B (en) | One treats paracmastic Chinese medicine composition of gout and preparation method thereof | |
| CN102106999A (en) | Chinese medicinal compound preparation for treating dysphagia due to stroke and preparation method thereof | |
| CN102406861B (en) | External medicament for treating bronchitis | |
| CN105056196A (en) | Medicine composition for treating peptic ulcer and preparing method thereof | |
| CN105031595A (en) | Traditional Chinese medicine tablet for treating nummular eczema and preparing method thereof | |
| CN112237622A (en) | External traditional Chinese medicine composition for pasting and applying for acute and chronic gastroenteritis, abdominal pain and diarrhea, application paste, preparation method and application | |
| CN104257986A (en) | Traditional Chinese medicine for treating nephritis | |
| CN104623381A (en) | Traditional-Chinese-medicine composition for treating skin disease caused by blood heat and liver depression | |
| CN104398725A (en) | Oral medicine for colorectal carcinoma fistulation later-stage nursing, and its preparation method | |
| CN109718283B (en) | Traditional Chinese medicine composition for relieving asthma and reducing phlegm and preparation method thereof | |
| CN114452369B (en) | Traditional Chinese medicine composition for treating breast cancer | |
| CN104069284A (en) | Traditional Chinese medicine preparation for treating calculus | |
| CN103285339B (en) | External medicine for treating bone pain disease | |
| CN110812451B (en) | Pain arthralgia pill and preparation method and application thereof | |
| CN101239136A (en) | Medicament for treating rheumatism | |
| CN105194555A (en) | Preparation method of traditional Chinese medicine composition for treating acute biliary tract infection | |
| CN103623355B (en) | A kind of Chinese medicine preparation for the treatment of the oblique hernia of sliding | |
| CN115120690A (en) | Traditional Chinese medicine composition for treating sexual precocity and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |